Abstract:Tongue squamous cell carcinoma (TSCC) is highly malignant and poorly differentiated, resulting in a high frequency of local recurrence and distant metastases. Sox2 (Sry-box2), an important factor in embryonic development and cell differentiation, has been shown to associate with malignant phenotypes and epithelial-mesenchymal transition (EMT) progression in numerous types of human tumors. However, the clinical relevance and molecular mechanisms of Sox2 in TSCC remain unclear. In the present study, the expression levels of Sox2 were assessed in 61 pairs of TSCC samples and corresponding adjacent non-cancerous tissues using immunohistochemical methods. Associations between Sox2 expression and clinicopathological features were evaluated. Furthermore, Sox2 was overexpressed and inhibited using full-length Sox2 cDNA and short hairpin RNA (shRNA) transfection in UM2 and Cal27 cell lines, respectively. The malignant phenotypes were assessed by plate clone formation assays, wound-healing assays and Transwell assays. EMT markers (E-cadherin, vimentin, Twist, Slug and Snail) and beta-catenin were detected by reverse transcription-polymerase chain reaction and western blot analysis following the alterations of Sox2 expression. The results indicated that Sox2 expression was markedly upregulated in TSCC samples and was significantly associated with tumor growth (pT stage), cell differentiation, lymphatic metastasis (pN stage) and clinical stage (pTNM stage). Cal27-shRNA-Sox2 cells not only exhibited a decreased capacity for cell proliferation, but also suppressed cell migration and invasion, and an attenuated colony formation capacity. By contrast, UM2-Sox2 cells exhibited accelerated cell malignant phenotypes and EMT progression. Moreover, when the expression of Sox2 was decreased by shRNA transduction, beta-catenin expression was attenuated. An opposing phenomenon was observed in UM2-Sox2 cells. In conclusion, this study suggests that Sox2 expression serves a role in TSCC malignant phenotypes and EMT progression, and that beta-catenin may act as a modulated factor in this progression.

Sox2 Promotes Tumor Aggressiveness and Epithelial‑mesenchymal Transition in Tongue Squamous Cell Carcinoma.

Silencing Sox2 Induced Mesenchymal-Epithelial Transition And Its Expression Predicts Liver And Lymph Node Metastasis Of Crc Patients

MTA3-SOX2 Module Regulates Cancer Stemness and Contributes to Clinical Outcomes of Tongue Carcinoma

SOX9 promotes stemness in the CAL27 cell line of tongue squamous cell carcinoma

Expression of SOX2 in Oral Squamous Cell Carcinoma and the Association with Lymph Node Metastasis.

Bmi1 Drives Stem-Like Properties and is Associated with Migration, Invasion, and Poor Prognosis in Tongue Squamous Cell Carcinoma

Correlation of ALDH1, CD44, OCT4 and SOX2 in Tongue Squamous Cell Carcinoma and Their Association with Disease Progression and Prognosis.

Sox2 Nuclear Expression is Closely Associated with Poor Prognosis in Patients with Histologically Node-Negative Oral Tongue Squamous Cell Carcinoma

SOX2 Promotes Tumor Metastasis by Stimulating Epithelial-to-mesenchymal Transition Via Regulation of WNT/β-catenin Signal Network.

TGFβ1‐Smad3‐Jagged1‐Notch1–Slug Signaling Pathway Takes Part in Tumorigenesis and Progress of Tongue Squamous Cell Carcinoma

Overexpression of HMGA2 Promotes Tongue Cancer Metastasis Through EMT Pathway

Abstract 294: Sox2 Remodels the Tumor Microenvironment Via Recruitment of Tregs

Genome-wide Gene Expression Profiling of Tongue Squamous Cell Carcinoma by RNA-seq

Targeted Silencing of Cxcr4 Inhibits Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma

Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma

Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells

Expression of Sox2 in Breast Cancer Cells Promotes the Recruitment of M2 Macrophages to Tumor Microenvironment.

High expression of Notch2 drives tongue squamous cell carcinoma carcinogenesis

Sod2 is A C-Myc Target Gene That Promotes the Migration and Invasion of Tongue Squamous Cell Carcinoma Involving Cancer Stem-Like Cells

The multiple roles for Sox2 in stem cell maintenance and tumorigenesis

Activation of Adrenergic Receptor Β2 Promotes Tumor Progression and Epithelial Mesenchymal Transition in Tongue Squamous Cell Carcinoma.